Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
Suzuki
S
S
Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Sumoto, Japan.
Sakamoto
S
S
Koide
M
M
Matsuo
M
M
Fujii
K
K
Matsuo
T
T
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010875:Pipecolic Acids / Q000627:therapeutic use*; D015607:Stents; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*
D000925:Anticoagulants; D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban